Abstract:BackgroundCrohn's disease (CD) is a chronic nonspecific inflammatory bowel disease (IBD) with an increasing incidence worldwide. The etiology of CD is still obscure, but microbial dysbiosis has been recognized as an essential factor contributing to CD. However, few studies have revealed the microbiome's signatures and reciprocal correlations between multiple sites in patients with CD over different disease stages. This study investigated the specific microbial architectures of the oral cavity, sputum, and ileum in patients with CD in the active and remission stages. MethodsMicrobial samples from the oral cavity, sputum, and ileum were collected from patients with CD in the active and remission stages and healthy controls. The microbial composition was assessed by 16S ribosomal RNA (rRNA) gene sequencing. In addition, bioinformatics methods were used to demonstrate the microbial signatures, functional changes, and correlations between microbiota and clinical data in CD. ResultsCompared with healthy controls, a distinct microbiota dysbiosis in the oral cavity, sputum, and ileum of patients with CD was identified, characterized by alterations in microbiota biodiversity and composition. The oral cavity and sputum microbiota showed significantly lower microbial diversity in patients with CD than in healthy controls. In terms of microbiota composition, the microbiota changes in the oral cavity of patients with CD were similar to those in the sputum, while they were different from those in the ileum. In the oral cavity and sputum of patients with CD, a lower relative abundance of Firmicutes and Actinobacteria was observed compared to healthy controls, which was most prominent in the active stage. In contrast, an increased relative abundance of Fusobacteria, Porphyromonas, and Haemophilus was observed in patients with CD. The predicted metabolic pathways involved in the oral cavity, sputum, and ileum were similar, predominantly involving metabolism, environmental information processing, and genetic information processing. ConclusionThe results revealed the alterations of microbiota architecture in the oral cavity, sputum, and ileum of patients with CD, which varied across disease stages. Studying microbiota dysbiosis may bring new insights into the etiology of CD and lead to novel treatments.

Correlation between altered gut microbiota and elevated inflammation markers in patients with Crohn’s disease

Integration of Taxa Abundance and Occurrence Frequency to Identify Key Gut Bacteria Correlated to Clinics in Crohn's Disease.

Alterations and correlations of ileum microbiota and serum metabolites in Crohn's disease

Correlation between intestinal flora and serum inflammatory factors in patients with Crohn's disease

Correlation of diet, microbiota and metabolite networks in inflammatory bowel disease

Enhanced Microbiota Profiling in Patients with Quiescent Crohn's Disease Through Comparison with Paired Healthy First-Degree Relatives.

CD177+ Neutrophils and Its Correlation with Mucosal Impairment in Patients with Inflammatory Bowel Disease

Dietary Inflammatory Potential Mediated Gut Microbiota and Metabolite Alterations in Crohn's Disease: A Fire-new Perspective

Correlation of the Intestinal Flora Distribution with the Serum TNF-α and IL-6 Levels in the Inflammatory Bowel Disease

Novel markers to evaluate the disease activity of rheumatoid arthritis based on some intestinal flora imbalance, abnormal immune cells and cytokines

Bacterial microbiome profiles of the inflamed terminal ileum mucosa in active Crohn’s disease patients

Molecular-Phylogenetic Characterization of the Microbiota in Ulcerated and Non-Ulcerated Regions in the Patients with Crohn's Disease

Enhanced microbiota profiling in patients with quiescent Crohn’s disease through comparison with paired healthy first-degree relatives using fecal metagenomics and metabolomics

Two Distinct Metacommunities Characterize the Gut Microbiota in Crohn'S Disease Patients

Dysbiosis of gut fungal microbiota is associated with mucosal inflammation in Crohn's disease.

Characterization of Specific Signatures of the Oral Cavity, Sputum, and Ileum Microbiota in Patients With Crohn's Disease

Fecal Fungal Microbiota Alterations Associated with Clinical Phenotypes in Crohn's Disease in Southwest China.

Fecal fungal microbiota alterations associated with clinical phenotypes in Crohn’s disease in southwest China

Gut Microbiota and Metabolite Changes in Patients With Ulcerative Colitis and Clostridioides difficile Infection

Changes of the fungal microbiota in inflamed intestinal mucosa of the patients with Crohn's disease

Bacterial Characteristics of Intestinal Tissues from Patients with Crohn’s Disease